| Description | Buflomedil is a vasoactive compound. Buflomedil has been used for peripheral arterial diseases. |
| Synonyms | Buflomedilum |
| molecular weight | 307.38 |
| Molecular formula | C17H25NO4 |
| CAS | 55837-25-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: Soluble |
| References | 1. de Backer TL, Vander Stichele R. Buflomedil for intermittent claudication. Cochrane Database Syst Rev. 2013 Mar 28;(3):CD000988. doi: 10.1002/14651858.CD000988.pub4. Review. PubMed PMID: 23543509. 2. Bucolo C, Longo L, Camillieri G, Drago F, Salomone S. Safety profile assessment of buflomedil: an overview of adverse reactions between 1975 and 2011. Pharmacoepidemiol Drug Saf. 2012 Nov;21(11):1190-6. doi: 10.1002/pds.3328. Epub 2012 Jul 31. Review. PubMed PMID: 22855302. 3. Tsantilas D, Hatzitolios AI, Tziomalos K, Karamitsos D, Papadimitriou D. Effects of buflomedil on skin blood flow in patients with type 2 diabetes mellitus without overt micro- or macroangiopathy. Int Angiol. 2011 Apr;30(2):164-71. PubMed PMID: 21427654. 4. Wu S, Zeng Q, Liu M, Yang J, He S, Lin S, Wu B. Buflomedil for acute ischaemic stroke. Cochrane Database Syst Rev. 2015 Jul 20;(7):CD009570. doi: 10.1002/14651858.CD009570.pub2. Review. PubMed PMID: 26193704. |